RGS9 (Serbian Wikipedia)
Analysis of information sources in references of the Wikipedia article "RGS9" in Serbian language version.
Last modified:
Ref.Un. Ref.Website
Global rank
Serbian rank
6th place
8th place
archive.org (Global: 6th place; Serbian: 8th place)
- Martemyanov KA, Krispel CM, Lishko PV, Burns ME, Arshavsky VY (2008). „Functional comparison of RGS9 splice isoforms in a living cell”. Proceedings of the National Academy of Sciences of the United States of America. 105 (52): 20988—93. PMC 2634932
. PMID 19098104. doi:10.1073/pnas.0808941106. - Zachariou V, Georgescu D, Sanchez N, Rahman Z, DiLeone R, Berton O, Neve RL, Sim-Selley LJ, Selley DE, Gold SJ, Nestler EJ (2003). „Essential role for RGS9 in opiate action”. Proceedings of the National Academy of Sciences of the United States of America. 100 (23): 13656—61. PMC 263869 . PMID 14595021. doi:10.1073/pnas.2232594100.
- Garzón J, Rodríguez-Muñoz M, López-Fando A, Sánchez-Blázquez P (2005). „Activation of mu-opioid receptors transfers control of Galpha subunits to the regulator of G-protein signaling RGS9-2: role in receptor desensitization”. The Journal of Biological Chemistry. 280 (10): 8951—60. PMID 15632124. doi:10.1074/jbc.M407005200.
doi.org (Global: 2nd place; Serbian: 5th place)
- Martemyanov KA, Krispel CM, Lishko PV, Burns ME, Arshavsky VY (2008). „Functional comparison of RGS9 splice isoforms in a living cell”. Proceedings of the National Academy of Sciences of the United States of America. 105 (52): 20988—93. PMC 2634932 . PMID 19098104. doi:10.1073/pnas.0808941106.
- Garzón J, Rodríguez-Díaz M, López-Fando A, Sánchez-Blázquez P (2001). „RGS9 proteins facilitate acute tolerance to mi-opioid effects”. The European Journal of Neuroscience. 13 (4): 801—11. PMID 11207815. doi:10.1046/j.0953-816x.2000.01444.x.
- Zachariou V, Georgescu D, Sanchez N, Rahman Z, DiLeone R, Berton O, Neve RL, Sim-Selley LJ, Selley DE, Gold SJ, Nestler EJ (2003). „Essential role for RGS9 in opiate action”. Proceedings of the National Academy of Sciences of the United States of America. 100 (23): 13656—61. PMC 263869 . PMID 14595021. doi:10.1073/pnas.2232594100.
- Sánchez-Blázquez P, Rodríguez-Muñoz M, Montero C, Garzón J (2005). „RGS-Rz and RGS9-2 proteins control mu-opioid receptor desensitisation in CNS: the role of activated Galphaz subunits”. Neuropharmacology. 48 (1): 134—50. PMID 15617734. doi:10.1016/j.neuropharm.2004.08.016.
- Garzón J, Rodríguez-Muñoz M, López-Fando A, Sánchez-Blázquez P (2005). „Activation of mu-opioid receptors transfers control of Galpha subunits to the regulator of G-protein signaling RGS9-2: role in receptor desensitization”. The Journal of Biological Chemistry. 280 (10): 8951—60. PMID 15632124. doi:10.1074/jbc.M407005200.
- Psifogeorgou K, Papakosta P, Russo SJ, Neve RL, Kardassis D, Gold SJ, Zachariou V (2007). „RGS9-2 is a negative modulator of mu-opioid receptor function”. Journal of Neurochemistry. 103 (2): 617—25. PMID 17725581. doi:10.1111/j.1471-4159.2007.04812.x.
- Hooks SB, Martemyanov K, Zachariou V (2008). „A role of RGS proteins in drug addiction”. Biochemical Pharmacology. 75 (1): 76—84. PMID 17880927. doi:10.1016/j.bcp.2007.07.045.
- Traynor JR, Terzi D, Caldarone BJ, Zachariou V (2009). „RGS9-2: probing an intracellular modulator of behavior as a drug target”. Trends in Pharmacological Sciences. 30 (3): 105—11. PMID 19211160. doi:10.1016/j.tips.2008.11.006.
- Blundell J, Hoang CV, Potts B, Gold SJ, Powell CM (2008). „Motor coordination deficits in mice lacking RGS9”. Brain Research. 1190: 78—85. PMC 2241663 . PMID 18073128. doi:10.1016/j.brainres.2007.11.017.
nih.gov (Global: 5th place; Serbian: 7th place)
ncbi.nlm.nih.gov
- „Entrez Gene: RGS9 regulator of G-protein signalling 9”.
- Martemyanov KA, Krispel CM, Lishko PV, Burns ME, Arshavsky VY (2008). „Functional comparison of RGS9 splice isoforms in a living cell”. Proceedings of the National Academy of Sciences of the United States of America. 105 (52): 20988—93. PMC 2634932 . PMID 19098104. doi:10.1073/pnas.0808941106.
- Garzón J, Rodríguez-Díaz M, López-Fando A, Sánchez-Blázquez P (2001). „RGS9 proteins facilitate acute tolerance to mi-opioid effects”. The European Journal of Neuroscience. 13 (4): 801—11. PMID 11207815. doi:10.1046/j.0953-816x.2000.01444.x.
- Zachariou V, Georgescu D, Sanchez N, Rahman Z, DiLeone R, Berton O, Neve RL, Sim-Selley LJ, Selley DE, Gold SJ, Nestler EJ (2003). „Essential role for RGS9 in opiate action”. Proceedings of the National Academy of Sciences of the United States of America. 100 (23): 13656—61. PMC 263869 . PMID 14595021. doi:10.1073/pnas.2232594100.
- Sánchez-Blázquez P, Rodríguez-Muñoz M, Montero C, Garzón J (2005). „RGS-Rz and RGS9-2 proteins control mu-opioid receptor desensitisation in CNS: the role of activated Galphaz subunits”. Neuropharmacology. 48 (1): 134—50. PMID 15617734. doi:10.1016/j.neuropharm.2004.08.016.
- Garzón J, Rodríguez-Muñoz M, López-Fando A, Sánchez-Blázquez P (2005). „Activation of mu-opioid receptors transfers control of Galpha subunits to the regulator of G-protein signaling RGS9-2: role in receptor desensitization”. The Journal of Biological Chemistry. 280 (10): 8951—60. PMID 15632124. doi:10.1074/jbc.M407005200.
- Psifogeorgou K, Papakosta P, Russo SJ, Neve RL, Kardassis D, Gold SJ, Zachariou V (2007). „RGS9-2 is a negative modulator of mu-opioid receptor function”. Journal of Neurochemistry. 103 (2): 617—25. PMID 17725581. doi:10.1111/j.1471-4159.2007.04812.x.
- Hooks SB, Martemyanov K, Zachariou V (2008). „A role of RGS proteins in drug addiction”. Biochemical Pharmacology. 75 (1): 76—84. PMID 17880927. doi:10.1016/j.bcp.2007.07.045.
- Traynor JR, Terzi D, Caldarone BJ, Zachariou V (2009). „RGS9-2: probing an intracellular modulator of behavior as a drug target”. Trends in Pharmacological Sciences. 30 (3): 105—11. PMID 19211160. doi:10.1016/j.tips.2008.11.006.
- Blundell J, Hoang CV, Potts B, Gold SJ, Powell CM (2008). „Motor coordination deficits in mice lacking RGS9”. Brain Research. 1190: 78—85. PMC 2241663 . PMID 18073128. doi:10.1016/j.brainres.2007.11.017.